| Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment JB Stokes, SJ Adair, JK Slack-Davis, DM Walters, RW Tilghman, ... Molecular cancer therapeutics 10 (11), 2135-2145, 2011 | 227 | 2011 |
| Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded … SJ Adair, KT Hogan Cancer immunology, immunotherapy 58, 589-601, 2009 | 144 | 2009 |
| Drp1 promotes KRas-driven metabolic changes to drive pancreatic tumor growth S Nagdas, JA Kashatus, A Nascimento, SS Hussain, RE Trainor, ... Cell reports 28 (7), 1845-1859. e5, 2019 | 111 | 2019 |
| Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor … DM Walters, JM Lindberg, SJ Adair, TE Newhook, CR Cowan, JB Stokes, ... Neoplasia 15 (2), 143-IN10, 2013 | 93 | 2013 |
| CD47 blockade as an adjuvant immunotherapy for resectable pancreatic cancer AD Michaels, TE Newhook, SJ Adair, S Morioka, BJ Goudreau, S Nagdas, ... Clinical Cancer Research 24 (6), 1415-1425, 2018 | 84 | 2018 |
| Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens DM Walters, JB Stokes, SJ Adair, EB Stelow, CA Borgman, BT Lowrey, ... PloS one 8 (10), e77065, 2013 | 78 | 2013 |
| CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response K Szlachta, C Kuscu, T Tufan, SJ Adair, S Shang, AD Michaels, ... Nature communications 9 (1), 4275, 2018 | 73 | 2018 |
| Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells X Wei, J Yang, SJ Adair, H Ozturk, C Kuscu, KY Lee, WJ Kane, PE O’Hara, ... Proceedings of the National Academy of Sciences 117 (45), 28068-28079, 2020 | 62 | 2020 |
| Electrophysiology-based stratification of pancreatic tumorigenicity by label-free single-cell impedance cytometry JS McGrath, C Honrado, JH Moore, SJ Adair, WB Varhue, A Salahi, ... Analytica chimica acta 1101, 90-98, 2020 | 51 | 2020 |
| Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer JM Lindberg, TE Newhook, SJ Adair, DM Walters, AJ Kim, EB Stelow, ... Neoplasia 16 (7), 562-571, 2014 | 41 | 2014 |
| A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest TE Newhook, EM Blais, JM Lindberg, SJ Adair, W Xin, JK Lee, JA Papin, ... PloS one 9 (9), e105631, 2014 | 38 | 2014 |
| Automated biophysical classification of apoptotic pancreatic cancer cell subpopulations by using machine learning approaches with impedance cytometry C Honrado, A Salahi, SJ Adair, JH Moore, TW Bauer, NS Swami Lab on a Chip 22 (19), 3708-3720, 2022 | 26 | 2022 |
| The TAG Family of Cancer/Testis Antigens is Widely Expressed in a Variety of Malignancies and Gives Rise to HLA-A2–Restricted Epitopes SJ Adair, TM Carr, MJ Fink, CL Slingluff Jr, KT Hogan Journal of Immunotherapy 31 (1), 7-17, 2008 | 19 | 2008 |
| Immunological profiling of a panel of human ovarian cancer cell lines TM Carr, SJ Adair, MJ Fink, KT Hogan Cancer Immunology, Immunotherapy 57, 31-42, 2008 | 19 | 2008 |
| Apoptotic bodies in the pancreatic tumor cell culture media enable label‐free drug sensitivity assessment by impedance cytometry C Honrado, SJ Adair, JH Moore, A Salahi, TW Bauer, NS Swami Advanced biology 5 (8), 2100438, 2021 | 14 | 2021 |
| ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer H Ozturk, H Cingoz, T Tufan, J Yang, SJ Adair, KS Tummala, C Kuscu, ... Developmental Cell 57 (11), 1331-1346. e9, 2022 | 13 | 2022 |
| Adjuvant trametinib delays the outgrowth of occult pancreatic cancer in a mouse model of patient-derived liver metastasis TE Newhook, JM Lindberg, SJ Adair, AJ Kim, EB Stelow, OE Rahma, ... Annals of surgical oncology 23, 1993-2000, 2016 | 10 | 2016 |
| Supervised learning on impedance cytometry data for label-free biophysical distinction of pancreatic cancer cells versus their associated fibroblasts under gemcitabine treatment A Salahi, C Honrado, J Moore, S Adair, TW Bauer, NS Swami Biosensors and Bioelectronics 231, 115262, 2023 | 7 | 2023 |
| Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer KA Knapp, ES Pires, SJ Adair, A Mandal, AM Mills, WC Olson, ... Oncotarget 9 (10), 8972, 2018 | 6 | 2018 |
| Abstract PO-007: PRMT5 inhibition sensitizes pancreatic cancer to gemcitabine in orthotopic and metastatic murine models WJ Kane, SJ Adair, S Nagdas, D Liu, X Wei, M Adli, TW Bauer Cancer Research 80 (22_Supplement), PO-007-PO-007, 2020 | 2 | 2020 |
Timothy NewhookAssistant Professor, Surgical Oncology, The University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
